The regulation of p42/p44 mitogen-activated protein kinases in the injured rat carotid artery

Journal of Surgical Research

Volumn 70, Issue 2, 1997, Pages 178-186

  Lille, Sean ^a   Daum, Günter ^a   Clowes, Monika M ^a   Clowes, Alexander W ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BROXURIDINE; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; THROMBIN; THROMBIN INHIBITOR; THROMBOPLASTIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTERY INJURY; ARTERY MUSCLE; ARTICLE; BLOOD CLOTTING; CAROTID ARTERY; CONTROLLED STUDY; ENZYME ACTIVITY; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER;

EID: 0031194177     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5114     Document Type: Article

References (55)

1. Ross R. The pathogensis of atherosclerosis: An update. N. Engl. J. Med. 314:1986;488.
2. Grondin C. M., Campeau L., Les'erance J. Comparison of late changes in internal mammary artery and saphenous vein grafts in two consecutive series of patients 10 years after operation. Circulation. 70:1984;1208.
3. Echave V., Koornick A. R., Haimov M. Intimal hyperplasia as a complication of the use of the polytetrafluoroethylene graft for femoral-popliteal bypass. Surgery. 86:1979;791.
4. Herrman J.-PR., Hermans W. R. M., Vos J., Serruys P. W. Pharmacological approaches to the prevention of restenosis following angioplasty: part II. Drugs. 46:1993;18.
5. Malarkey K., Belham C. M., Paul A., Graham A., Mclees A., Scott P. H., Plevin R. The regulation of tyrosine kinase signalling pathways by growth factor and G-protein-coupled receptors. Biochem. J. 309:1995;361.
6. Clowes A. W., Karnovsky M. J. Suppression of heparin of smooth muscle cell proliferation in injured arteries. Nature. 265:1977;620.
7. Lindner V., Reidy M. A. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc. Natl. Acad. Sci. 88:1991;3739.
8. Fingerle J., Johnson R., Clowes A. W. Role of Platelets in smooth muscle cell proliferation and migration after vascular injury in the rat carotid artery. Proc. Natl. Acad. Sci. USA. 86:1989;8412.
9. Schwartz S. M., deBlois D., O'Brien E. R. M. The intima: Soil for atherosclerosis and restenosis. Circ. Res. 77:1995;445.
10. Lin L. L., Wartmann M., Yin A. Y., Knopf J. L., Seth A., Davis R. J. cPLA2 is phosphorylated and activated by MAPK kinase. Cell. 72:1993;269-278.
11. Merrall N. W., Plevin R. J., Stokoe D., Cohen P., Nebreda A. R., Gould G. W. Mitogen-activated protein kinase (MAPK kinase), MAPK kinase kinase and c-Mos stimulate glucose transport inXenopus. Biochem. J. 295:1993;351.
12. Alvarez E., Northwood I. C., Gonzalez D. A. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J. Biol. Chem. 266:1991;15277.
13. Golomb G., Fishbein I., Banai S. Controlled delivery of a tyrphostin inhibits intimal hyperplasia in a rat carotid artery injury model. Atherosclerosis. 125:1996;171.
14. Indolfi C., Avvedimento E. V., Rapacciuolo A., Di Lorenzo E., Esposito G., Stabile E., Feliciello A., Mele E., Guiliano. Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo. Nature Med. 6:1995;541.
15. Ferns G. A., Raines E. W., Sprugel K. H. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. 253:1991;1129.
16. Jang Y., Guzman L. A., Lincoff A. M., Gottsauner-Wolf M., Forudi F., Hart C. E., Courtman D. W., Ezban M., Ellis S. G., Topol E. J. Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation. 92:1995;3041.
17. Deibler G. E., Martenson R. E., Kies M. W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139.
18. Gotoh Y., Nishida E., Yamashita T., Hoshi M., Kawakami M., Sakai H. Microtubule-associated protein (MAP) kinase activated by nerve growth factor and epidermal growth factor in PC12 cells. Identity with the MAPK of fibroblastic cells. Eur. J. Biochem. 193:1990;661.
19. Cobb M. H., Boulton T. G., Robbins D. J. Extracellular signal related kinases: ERKs in progress. Cell. Regul. 2:1991;965.
20. L'Alleman G. Deciphering the MAP kinase pathway. Prog. Growth Factor Res. 5:1994;291.
21. Shisuke M. I. I., Khalil R. A., Morgan K. G. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am. J. Physiol. 270:1996;H142.
22. Reidy M. A., Fingerle J., Linder V. Factors controlling the development of arterial lesions after injury. Circ. Res. 86:1992;III-43-III-46.
23. Crowley S. T., Ray C., Nawaz D., Majack R. A., Horwitz L. D. Multiple growth factors are released from mechanically injured vascular smooth muscle cells. Am. J. Physiol. 269:1995;H1641.
24. Ottlinger M. E., Pukac L. A., Karnovsky M. J. Heparin inhibits mitogen-activated protein kinase in intact rat vascular smooth muscle cells. J. Biol. Chem. 268:1993;19173.
25. Chao M. V. Growth factor signaling; Where is the specificty? Cell. 68:1992;995.
26. Selva E., Raden D. L., Davis R. J. Mitogen-activated protein kinase stimulation by a tyrosine kinase-negative epidermal growth factor receptor. J. Biol. Chem. 268:1993;14553.
27. Seger R., Seger D., Reska A., Munar E. S., Finkleman H., Dobrowski G., Jensen A. M., Campbell J. S., Fisher E. H., Krebs E. G. Overexpression of MAPKK and its mutants in NIH 3T3 cells. J. Biol. Chem. 269:1994;25699.
28. Cowley S., Paterson H., Kemp P., Marshall C. J. Activation of MAPKK is necessary and sufficient for PC12 differentiation and for transformation in NIH 3T3 cells. Cell. 77:1994;841.
29. Meloche S., Seuwen K., Pages G., Pouyssegeur J. Biphasic and synergistic activation of p44 MAPK by growth factors: Correlation between late phase activation and mitogenicity. Mol. Endocrinol. 6:1992;845.
30. Childs T. J., Watson M. H., Sanghera J. S., Campbell D. L., Pelech S. L., Mak A. S. Phosphorylation of smooth muscle caldesmon by mitogen-activated protein (MAP) kinase and expression of MAP kinase in differentiated smooth muscle cells. J. Biol. Chem. 267:1992;22853.
31. Adam L. P., Franklin M. T., Raff G. J., Hathaway D. R. Activation of mitogen-activated protein kinase in porcine carotid arteries. Circ. Res. 76:1995;183.
32. Lai K., Wang H., Lee W. S., Jain M. K., Lee M. E., Haber E. Mitogen-activated protein kinase phosphatase-1 in rat arterial smooth muscle cell proliferation. J. Clin. Invest. 98:1996;1560.
33. Linder V., Lappi D. A., Baird A., Majack R. A., Reidy M. A. Role of fibroblast growth factor in vascular lesion formation. Circ. Res. 68:1991;106.
34. Walker L. N., Bowen-Pope D. F., Reidy M. A. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc. Natl. Acad. Sci. USA. 88:1986;3739.
35. Indolfi C., Esposito G., Di Lorenzo E., Rapacciuolo A., Feliciello A., Porcellini A., Avvedimento V. E., Condorelli M., Chiariello M. Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation. 92:1995;1230.
36. Jawien A., Bowen-Pope D. F., Lindner V., Schwartz S. M., Clowes A. W. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J. Clin. Invest. 89:1991;507.
37. Clowes A. W., Clowes M. M. Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle cell growth by heparin. Lab. Invest. 52:1985;611.
38. Wright T. C., Pukac L. A., Castellot J. J., Karnovsky M. J., Levine R. A., Kim H. Y., Campisi J. Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. USA. 86:1989;3199.
39. Au Y. P. T., Kenagy R. D., Clowes A. W. Heparin selectively inhibits the transcription of tissue-type plasminogen activator in primate arterial smooth muscle cells during mitogenesis. J. Biol. Chem. 267:1992;3438.
40. Lindner V., Olson N. E., Clowes A. W., Reidy M. A. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor. J. Clin. Invest. 90:1992;2044.
41. Nelken N. A., Soifer S. J., O'Keefe J., Vu T. K., Charo I. F., Coughlin S. R. Thrombin receptor expression in normal and atherosclerotic human arteries. J. Clin. Invest. 90:1992;1614.
42. Vu T. K., Hung D. T., Wheaton V. I., Coughlin S. R. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057.
43. Harlan J. M., Thompson P. J., Ross R., Bowen-Pope D. F. Alpha-thrombin induces release of platlelet-derived growth factor-like molecules by cultured endothelial cells. J. Cell. Biol. 103:1986;1129.
44. Bar-Shavit R., Kahn A. J., Mann K. G., Wilner G. D. Identification of a thrombin sequence with growth factor activity on macrophages. Proc. Natl. Acad. Sci. USA. 83:1986;976.
45. Walters T. K., Gorog D. A., Wood R. F. M. Thrombin generation following arterial injury is a critical initiating event in the pathogenesis of the proliferative stages of atherosclerotic process. J. Vasc. Res. 31:1994;173.
46. Rade J. J., Schulick A. H., Virmani R., Dichek D. A. Local adenoviral-mediated expression of recombinant hirudin reduces neointima formation after arterial injury. Nat. Med. 2:1996;293.
47. Stouffer G. A., Schmedtje J. F., Gulba D., Huber K., Bode C., Aaron J., Runge M. S. Restenosis following percutaneous revascularization - The potentail role of thrombin and the thrombin receptor. Ann. Hematol. 73:1996;S39.
48. Coughlin S. R., Vu T. K., Hung D. T., Wheaton V. I. Characterization of a functional thrombin receptor. Issues and opportunities. J. Clin. Invest. 89:1992;351.
49. Speidel C. M., Thorton D. J., Meng Y. Y., Eisenberg P. R., Edgington T. S., Abendschein D. R. Procoagulant activity on injured arteries and associated thrombi is mediated primarily by the complex of tissue factor and factor VIIa. Coronary Artery Dis. 7:1996;57.
50. Rao G. N., Delafontaine P., Runge M. S. Thrombin stimulates phosphorylation of insulin-like growth factor-1, insulin receptor substrate-1, and phospholipase C-gamma 1 in rat aortic smooth muscle cells. J. Biol. Chem. 270:1995;27871.
51. Ahn N. G., Seger R., Bratlein R. L., Diltz N. K., Tonks N. K., Krebs E. G. Multiple components in an epidermal growth factor-stimulated protein kinase cascade: In vitro activation of a myelin basic protein/microtubule associated protein 2 kinase. J. Biol. Chem. 266:1991;4220.
52. Thommes K. B., Hoppe J., Vetter H., Sachinidis A. The synergistic effect of PDGF-AA and IGF-1 on vascular smooth muscle cell proliferation might be explained by the differential activation of their intracellular signaling pathways. Exp. Cell Res. 226:1996;59.
53. Koide M., Kawahara Y., Tsuda T., Ishida Y., Shii K., Yokohama M. Endothelin-1 stimulates tyrosine phosphorylation and the activities of two mitogen-activated protein kinases in cultured vascular smooth muscle cells. J. Hyperten. 10:1992;1173.
54. Duff J. L., Marrero M. B., Paxton W. G., Charles C. H., Lau L. F., Bernstein K. E., Berk B. C. Angiotensisn II stimulates the pp44 and pp42 mitogen-activated protein kinases in cultured rat smooth muscle cells. Biochem. Biophys. Res. Commun. 188:1992;257.
55. Morinelli T. A., Zhang L. M., Newman W. H., Meier K. E. Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J. Biol. Chem. 269:1994;5693.